Japan Tissue Engineering Co (TSE:7774) Market Cap: 円25,584 Mil (As of Jul. 09, 2026)


TSE:7774 Japan Tissue Engineering Co Ltd TSE:7774
60 GF Score
Price 円630.00
GF Value 円517.18
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Japan Tissue Engineering Co Market Cap?

Japan Tissue Engineering Co TSE:7774 -0.32% 60 Market Cap is 円25,584 Mil as of Jul. 09, 2026. GuruFocus rates TSE:7774 with a GF Score™ of 60/100 and a GF Value™ of 円517.18 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 1,421 Biotechnology companies, Japan Tissue Engineering Co ranks better than 53.76% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Japan Tissue Engineering Co's share price for the quarter that ended in Mar. 2026 was 円596. Japan Tissue Engineering Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 41 Mil. Therefore, Japan Tissue Engineering Co's market cap for the quarter that ended in Mar. 2026 was 円24,204 Mil.

Japan Tissue Engineering Co's quarterly market cap increased from Mar. 2025 (円18,559 Mil) to Sep. 2025 (円20,386 Mil) and increased from Sep. 2025 (円20,386 Mil) to Mar. 2026 (円24,204 Mil).

Japan Tissue Engineering Co's annual market cap declined from Mar. 2024 (円27,168 Mil) to Mar. 2025 (円18,559 Mil) but then increased from Mar. 2025 (円18,559 Mil) to Mar. 2026 (円24,204 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Japan Tissue Engineering Co's Enterprise Value for Today is 円22,334 Mil.


Japan Tissue Engineering Co  (TSE:7774) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Japan Tissue Engineering Co Market Cap Related Terms


Japan Tissue Engineering Co Market Cap Historical Data

* Premium members only.

The historical data trend for Japan Tissue Engineering Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Tissue Engineering Co Market Cap Chart

Japan Tissue Engineering Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,832.93 21,157.81 27,168.09 18,558.77 24,203.56

Japan Tissue Engineering Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27,168.09 20,792.32 18,558.77 20,386.22 24,203.56

TSE:7774 vs VRTX, REGN, ALNY: Market Cap Comparison

For the Biotechnology subindustry, Japan Tissue Engineering Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Tissue Engineering Co Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's Market Cap falls into.


TSE:7774
60GF Score
Japan Tissue Engineering Co Ltd TSE:7774
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Tissue Engineering Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Japan Tissue Engineering Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as

Market Cap (A: Mar. 2026 )=Share Price (A: Mar. 2026 )*Shares Outstanding (EOP) (A: Mar. 2026 )
=円596*40.610
=円24,204

Japan Tissue Engineering Co's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=円596*40.610
=円24,204

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of 円25,584 Mil mean?
Japan Tissue Engineering Co (TSE:7774) has a Market Cap of 円25,584 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Japan Tissue Engineering Co and its competitors. According to the industry distribution chart, Japan Tissue Engineering Co ranks #657 out of 1421 companies in the Biotechnology industry, placing it in the top 46.2%.
Is Japan Tissue Engineering Co's Market Cap too high?
Japan Tissue Engineering Co's current Market Cap is 円25,584 Mil. Based on the distribution chart, Japan Tissue Engineering Co ranks #657 out of 1421 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Japan Tissue Engineering Co has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Tissue Engineering Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Japan Tissue Engineering Co ranks #657 out of 1421 companies for Market Cap. This puts Japan Tissue Engineering Co in the upper half of its industry. The industry median Market Cap is 119.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.86, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Japan Tissue Engineering Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Tissue Engineering Co's current Market Cap is 円25,584 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Tissue Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Tissue Engineering Co (TSE:7774) is currently considered Modestly Overvalued. The stock's GF Value™ is 円517.18, compared to a current price of 円630.00 — trading 21.8% above its estimated fair value. The current Market Cap is 円25,584 Mil. Japan Tissue Engineering Co's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Japan Tissue Engineering Co (TSE:7774), the current Market Cap is 円25,584 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Tissue Engineering Co (TSE:7774) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Tissue Engineering Co stock appears to be overvalued. The current stock price of 円630.00 is trading 21.8% above its estimated GF Value™ of 円517.18. GuruFocus considers Japan Tissue Engineering Co to be Modestly Overvalued.

Key valuation signals for TSE:7774:

  • Market Cap: 円25,584 Mil
  • GF Value™: 円517.18 vs. price of 円630.00 (21.8% above fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the TSE:7774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Tissue Engineering Co Business Description

Address 6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.
60GF Score

Get the complete analysis for TSE:7774

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円630.00
Price
円517.18
GF Value